Manish Tandon, CFO and Co-Founder Curadev

“I have know Tim for over 10 years. Throughout our collaboration with Roche, he continually demonstrated exceptional communication skills, strategic vision , and an unwavering commitmnet to the success of the collaboration. He truly beleives that the moTim was a fantastic partner across the table as we built the agreements to license bitopertin from Roche and enable Disc Medicine to bring the program forward into a rare disease desperately in need of new therapies. He was able to negotiate fairly with us and manage the internal processes at Roche to create a true win-win collaboration.”